Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion type Assertion NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_head.
- NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion description "[Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P<0.03 for all the cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_provenance.
- NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion evidence source_evidence_literature NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_provenance.
- NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion SIO_000772 21408220 NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_provenance.
- NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion wasDerivedFrom befree-20140225 NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_provenance.
- NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_assertion wasGeneratedBy ECO_0000203 NP580771.RAzamV_qQdGPnSwMSoIg2qDZTVBWk6qHNy2sjwkU6uQSQ130_provenance.